AbCellera Biologics Inc. (ABCL): Total Assets
$1.36B
As of 2025-12-31
$1.31B
As of 2026-06-30
-4.1%
3-year compound annual growth
+6.2%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.36B | -0.3% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $1.36B | -8.6% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $1.49B | -3.4% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $1.54B | +16.9% | 2024-02-20, Balance as of period end |
| 2021-12-31 | $1.32B | +31.1% | 2023-02-21, Balance as of period end |
| 2020-12-31 | $1.01B | n/a | 2022-02-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | $1.36B | -0.3% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $151.57M | +25.7% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $717.60M | -25.0% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $257.59M | +116.2% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $899.42M | +21.1% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $92.11M | +21.0% |
| ADC Therapeutics SA (ADCT) | 2025-12-31 | $323.15M | +0.4% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $57.15M | -3.5% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $271.15M | -21.2% |
Compare ABCL, CTMX, BCYC, ASMB side by side · Screen every company in Pharmaceutical Preparations ↗